Ventas (NYSE:VTR) Price Target Raised to $99.00

Ventas (NYSE:VTR) had its price objective boosted by equities researchers at UBS Group from $90.00 to $99.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group‘s price objective indicates a potential upside of 9.56% from the company’s current price.

Other analysts also recently issued reports about the company. JPMorgan Chase & Co. raised their target price on Ventas from $94.00 to $104.00 and gave the company an “overweight” rating in a research note on Wednesday, September 2nd. Jefferies Financial Group cut their price target on Ventas from $102.00 to $95.00 in a research note on Monday, October 12th. The Goldman Sachs Group increased their price target on Ventas from $110.00 to $114.00 and gave the company a “buy” rating in a report on Friday, July 24th. Wells Fargo & Company reduced their price target on Ventas from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, October 19th. Finally, BNP Paribas Exane raised their price objective on Ventas from $93.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 30th. Seventeen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $99.68.

Ventas Stock Up 0.0%

Ventas stock traded up $0.03 during midday trading on Wednesday, hitting $90.36. 2,368,020 shares of the company were exchanged, compared to its average volume of 3,646,908. The company has a market cap of $47.79 billion, a PE ratio of 170.50, a price-to-earnings-growth ratio of 3.67 and a beta of 0.77. Ventas has a fifty-two week low of $73.82 and a fifty-two week high of $101.60. The company’s fifty day moving average price is $86.55 and its 200-day moving average price is $86.83. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.43 and a quick ratio of 0.43.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Tuesday, October 27th. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.98 by ($0.85). The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.77 billion. Ventas had a net margin of 3.86% and a return on equity of 1.86%. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.88 EPS. On average, research analysts predict that Ventas will post 3.89 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Ventas during the 2nd quarter valued at approximately $4,953,439,000. Dimensional Fund Advisors LP boosted its holdings in Ventas by 3.6% in the first quarter. Dimensional Fund Advisors LP now owns 7,190,594 shares of the real estate investment trust’s stock worth $588,045,000 after purchasing an additional 253,019 shares during the period. Legal & General Group Plc bought a new stake in Ventas during the second quarter valued at $501,850,000. Deutsche Bank AG bought a new stake in Ventas during the second quarter valued at $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Ventas by 5.5% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,981,404 shares of the real estate investment trust’s stock valued at $442,349,000 after purchasing an additional 258,859 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

About Ventas

Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.